These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6259671)

  • 21. Effect of water-soluble polymers on naproxen complexation with natural and chemically modified beta-cyclodextrins.
    Faucci MT; Mura P
    Drug Dev Ind Pharm; 2001 Oct; 27(9):909-17. PubMed ID: 11763468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta- cyclodextrin complexation improves absorption and gastric tolerability of piroxicam.
    Cadel S; Bongrani S
    Acta Physiol Hung; 1990; 75 Suppl():45-6. PubMed ID: 2371898
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular modeling of beta-cyclodextrin drug inclusion complexes based on NMR-interaction measurements.
    Wiese M; Backensfeld T; Chi H; Müller B; Seydel JK
    Prog Clin Biol Res; 1989; 291():233-6. PubMed ID: 2726853
    [No Abstract]   [Full Text] [Related]  

  • 24. Formation of a complex between the analgesic, 6-benzoyl-benzoxazolidinone (CERM 10194), and beta-cyclodextrin.
    Si-Nang L; Simond J; Schiff V; Trottier D; Pourrat A
    Pharm Acta Helv; 1985; 60(4):112-6. PubMed ID: 4011622
    [No Abstract]   [Full Text] [Related]  

  • 25. Asymmetric oscillations in cyclodextrin--a molecular dynamics study.
    Prabhakaran M; Harvey SC
    Biopolymers; 1987 Jul; 26(7):1087-96. PubMed ID: 3620575
    [No Abstract]   [Full Text] [Related]  

  • 26. [Inclusion complexation of p-hydroxybenzoic acid esters with alpha- and beta-cyclodextrins: dissolution behaviors and antimicrobial activities (author's transl)].
    Uekama K; Ikeda Y; Hirayama F; Otagiri M; Shibata M
    Yakugaku Zasshi; 1980 Oct; 100(10):994-1003. PubMed ID: 7218148
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyclodextrin-stabilized volatile substances for inhalation therapy.
    Gál-Füzy M; Szente L; Szejtli J; Harangi J
    Pharmazie; 1984 Aug; 39(8):558-9. PubMed ID: 6504980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Enhanced bioavailability of phenytoin by beta-cyclodextrin complexation (author's transl].
    Tsuruoka M; Hashimoto T; Seo H; Ichimasa S; Ueno O; Fujinaga T; Otagiri M; Uekama K
    Yakugaku Zasshi; 1981 Apr; 101(4):360-7. PubMed ID: 7288580
    [No Abstract]   [Full Text] [Related]  

  • 29. Different mode of prednisolone within alpha-, beta-, and gamma-cyclodextrins in aqueous solution and in solid state.
    Uekama K; Sakai A; Arimori K; Otagiri M; Saitô H
    Pharm Acta Helv; 1985; 60(4):117-21. PubMed ID: 4011623
    [No Abstract]   [Full Text] [Related]  

  • 30. [Beta-cyclodextrin as an auxiliary substance in tabletting (preliminary communication)].
    Krajnyák J; Rácz I; Dávid A; Szejtli J
    Acta Pharm Hung; 1984 Mar; 54(2):90-1. PubMed ID: 6730980
    [No Abstract]   [Full Text] [Related]  

  • 31. Simulation of pharmacokinetic behaviour of drug-cyclodextrin complexes.
    Habon I; Fritsch S; Szejtli J
    Pharmazie; 1984 Dec; 39(12):830-4. PubMed ID: 6531392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of products containing mebendazole and beta-cyclodextrin.
    Kata M; Papp L
    Pharmazie; 1987 Jan; 42(1):65-6. PubMed ID: 3575409
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmaceutical applications of cyclodextrin complexations (author's transl)].
    Uekama K
    Yakugaku Zasshi; 1981 Oct; 101(10):857-73. PubMed ID: 7040632
    [No Abstract]   [Full Text] [Related]  

  • 34. [Enhanced bioavailability of acetohexamide by beta-cyclodextrin complexation (author's transl)].
    Uekama K; Matsuo N; Hirayama F; Ichibagase H; Arimori K; Tsubaki K; Satake K
    Yakugaku Zasshi; 1980 Sep; 100(9):903-9. PubMed ID: 7218151
    [No Abstract]   [Full Text] [Related]  

  • 35. Intestinal absorption of 14C-labelled beta-cyclodextrin in rats.
    Szejtli J; Gerlóczy A; Fónagy A
    Arzneimittelforschung; 1980; 30(5):808-10. PubMed ID: 7190424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of a sulfamethoxazole-beta-cyclodextrin complex in suppositories].
    Tóth K; Apostol I
    Acta Pharm Hung; 1986 May; 56(3):133-7. PubMed ID: 3739726
    [No Abstract]   [Full Text] [Related]  

  • 37. Enhancement of pharmacological activity of CERM 3726 with a ground mixture of beta-cyclodextrin in mice.
    Luu SN; Chaperon F; Leinot M; Pourrat A
    Pharm Acta Helv; 1987; 62(12):335-6. PubMed ID: 3441478
    [No Abstract]   [Full Text] [Related]  

  • 38. [Improvement in pharmacological properties of thiopental by gamma-cyclodextrin complexation].
    Arimori K; Iwaoku R; Nakano M; Uemura Y; Otagiri M; Uekama K
    Yakugaku Zasshi; 1983 May; 103(5):553-8. PubMed ID: 6644545
    [No Abstract]   [Full Text] [Related]  

  • 39. [Stabilization and reduction of irritant taste of anti-inflammatory drug pirprofen by beta-cyclodextrin complexation].
    Hibi T; Tatsumi M; Hanabusa M; Higuchi R; Imai T; Otagiri M; Uekama K
    Yakugaku Zasshi; 1984 Sep; 104(9):990-6. PubMed ID: 6335527
    [No Abstract]   [Full Text] [Related]  

  • 40. Inclusion complexes of cyclodextrins with organic drug molecules.
    Uekama K
    Jpn J Antibiot; 1979 Dec; 32 Suppl():S103-11. PubMed ID: 398896
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.